Business Context and Reporting Period
This Form 8-K filing by Nephros, Inc. (NEPH) reports a corporate governance event dated October 28, 2020. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change in board composition and does not contain financial performance data.
Material Changes
- Board Departure: Paul A. Mieyal resigned from the Board of Directors effective immediately on October 28, 2020.
- Reason for Departure: The resignation was not due to any disagreement with the Company.
- Succession Rights: Mr. Mieyal was one of two directors nominated pursuant to a 2007 investor rights agreement with entities affiliated with Wexford Capital LP ("Wexford"). Wexford retains the right to nominate his successor.
- Board Status: Until Wexford nominates a successor, one seat on the Board of Directors will remain vacant.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed in this report other than the temporary vacancy on the Board of Directors.
Investor Verification Checklist
- Confirm the current composition of the Board of Directors and the status of the vacant seat.
- Monitor future filings for the nomination of Mr. Mieyal's successor by Wexford Capital LP.
- Review the 2007 investor rights agreement to understand the full scope of Wexford's governance rights.